HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raymond R Tubbs Selected Research

Burkitt Lymphoma (Burkitt's Lymphoma)

2/2015Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.
10/2012Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raymond R Tubbs Research Topics

Disease

37Neoplasms (Cancer)
01/2019 - 01/2002
22Breast Neoplasms (Breast Cancer)
01/2016 - 01/2005
11Lymphoma (Lymphomas)
02/2015 - 06/2002
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2015 - 04/2010
6Neoplasm Metastasis (Metastasis)
12/2013 - 01/2005
4Disease Progression
01/2019 - 01/2005
4B-Cell Lymphoma (Lymphoma, B Cell)
02/2015 - 05/2012
4Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2015 - 03/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2014 - 05/2013
4Adenocarcinoma
05/2012 - 04/2005
3Uveal melanoma
01/2019 - 08/2009
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2015 - 11/2013
2Burkitt Lymphoma (Burkitt's Lymphoma)
02/2015 - 10/2012
2Hemangiosarcoma (Angiosarcoma)
03/2014 - 02/2012
2Leukemia
02/2014 - 03/2013
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2013 - 05/2012
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2013 - 08/2002
2Carcinoma (Carcinomatosis)
08/2011 - 03/2006
2Myxoma (Myxomas)
04/2011 - 01/2008
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2009 - 04/2006
2Liposarcoma
01/2009 - 08/2008
2Sarcoma (Soft Tissue Sarcoma)
08/2008 - 01/2008
2Multiple Myeloma
09/2006 - 04/2006
2Oligodendroglioma
10/2003 - 10/2002
1Pathologic Complete Response
01/2016
1Ductal Carcinoma
01/2016
1Chronic Kidney Failure (Chronic Renal Failure)
05/2015
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
05/2014
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
05/2014
1T-Cell Lymphoma (Lymphoma, T Cell)
05/2014
1Extranodal NK-T-Cell Lymphoma
05/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
05/2014
1Adenocarcinoma of Lung
12/2013
1Acute Promyelocytic Leukemia
03/2013
1Lymphoid Leukemia
05/2012
1Colonic Neoplasms (Colon Cancer)
05/2012
1Heavy Chain Disease
04/2012
1Lymphedema (Milroy Disease)
02/2012
1Abnormal Karyotype
11/2011
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2011
1Malignant Fibrous Histiocytoma
04/2011
1Synovial Sarcoma (Synovioma)
12/2009

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2005
16ParaffinIBA
11/2014 - 03/2003
13Formaldehyde (Formol)FDA Link
11/2014 - 04/2006
8Messenger RNA (mRNA)IBA
01/2019 - 03/2003
7Trastuzumab (Herceptin)FDA Link
01/2016 - 03/2005
5Estrogen ReceptorsIBA
07/2009 - 07/2006
4Biological ProductsIBA
05/2014 - 03/2005
4Immunoglobulins (Immunoglobulin)IBA
11/2013 - 03/2003
4Monoclonal AntibodiesIBA
03/2010 - 04/2006
4DNA (Deoxyribonucleic Acid)IBA
04/2006 - 01/2002
3Anaplastic Lymphoma KinaseIBA
05/2014 - 04/2014
3CrizotinibIBA
04/2014 - 05/2013
3SilverIBA
03/2014 - 03/2007
3RNA (Ribonucleic Acid)IBA
11/2013 - 10/2012
3Rituximab (Mabthera)FDA Link
10/2013 - 12/2011
3AntigensIBA
08/2013 - 05/2007
3human ERBB2 proteinIBA
10/2008 - 09/2006
3Nucleic AcidsIBA
05/2007 - 03/2005
3Progesterone Receptors (Progesterone Receptor)IBA
03/2007 - 07/2006
3Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
02/2007 - 08/2002
2Biomarkers (Surrogate Marker)IBA
01/2016 - 05/2004
2MicroRNAs (MicroRNA)IBA
02/2015 - 05/2012
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
02/2015 - 11/2013
2ErbB Receptors (EGF Receptor)IBA
11/2014 - 09/2006
2carboxyl radical (COO-)IBA
02/2014 - 06/2011
2Cyclin D1IBA
12/2013 - 04/2006
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2012 - 12/2011
2Prednisone (Sone)FDA LinkGeneric
10/2012 - 12/2011
2Vincristine (Oncovin)FDA LinkGeneric
10/2012 - 12/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2012 - 12/2011
2N 30IBA
05/2012 - 08/2008
2CyclinsIBA
05/2012 - 04/2006
2Epidermal Growth Factor (EGF)IBA
08/2011 - 04/2005
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2009 - 12/2005
2Hormones (Hormone)IBA
09/2006 - 01/2005
1CC ChemokinesIBA
01/2019
1LigandsIBA
01/2019
1ChemokinesIBA
01/2019
1Brentuximab VedotinIBA
05/2015
1Tyrosine Kinase InhibitorsIBA
11/2014
1AntibodiesIBA
10/2014
1EpitopesIBA
10/2014
1UbiquitinIBA
04/2014
1HaptensIBA
03/2014
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
03/2013
1OligonucleotidesIBA
11/2011
1Phosphotransferases (Kinase)IBA
02/2011
1Immunoglobulin M (IgM)IBA
01/2010
1Co-Repressor ProteinsIBA
12/2009
1Mucin-1 (CA 15-3 Antigen)IBA
12/2009

Therapy/Procedure

23Therapeutics
01/2016 - 01/2002
4Drug Therapy (Chemotherapy)
10/2012 - 04/2005
2Precision Medicine
05/2014 - 03/2013
2Stem Cell Transplantation
04/2014 - 10/2013
1Neoadjuvant Therapy
01/2016
1Transplantation
10/2013
1Autologous Transplantation
10/2013
1Radiotherapy
02/2012